Arca biopharma enters into amendment on demand sales agreement with jonestrading institutional services

Arca biopharma - entered into amendment no. 8 to capital on demand sales agreement with jonestrading institutional services.arca biopharma - amendment increased maximum offering value of shares which co may issue & sell from time to time to $32.4 million.arca biopharma - believes cash & cash equivalents will be sufficient to fund operations through end of q3 2021.
ABIO Ratings Summary
ABIO Quant Ranking